Strategic approaches for early clinical trials in neurodegenerative diseases

1:02:36

Webinar: Best practices in global flow cytometry quality control and harmonisation

31:35

Webinar: Meeting sites where they are: A connected, intelligence-powered operating model

59:48

Becoming a sponsor of choice for high-performing sites

59:59

Webinar: When patients lead: Breaking barriers in ultra-rare disease drug development

1:03:03

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Learn how early COA strategy decisions can reduce clinical trial risks and strengthen evidence.

1:01:56